Lancashire and South Cumbria
Formulary
 
back
6 Endocrine system
06-07-01 Bromocriptine and other dopaminergic drugs
CSM advice: Fibrotic reactions with ergot-derived dopamine receptor agonists - see BNF
Bromocriptine
Formulary

Tablets 2.5mg

Hyperprolactinaemic disorders.

Healthcare professionals are reminded that bromocriptine should only be used for prevention or suppression of postpartum lactation where medically indicated, in cases such as intrapartum loss, neonatal death, or a mother with HIV infection. It should not be used for routine suppression of lactation, or for relieving symptoms of postpartum breast pain and engorgement. Blood pressure should be carefully monitored, especially during the first days of treatment.

Link  MHRA: Ergot-derived dopamine agonists: risk of fibrotic reactions

Amber 0 View adult BNF  View SPC online  View childrens BNF
Cabergoline
Formulary

Tablets 500micrograms, 1mg, 2mg

Hyperprolactinaemic disorders.

Link  MHRA: Ergot-derived dopamine agonists: risk of fibrotic reactions

Amber 0 View adult BNF  View SPC online  View childrens BNF
Quinagolide
Formulary

Hyperprolactinaemic disorders.

Third line.

 


Amber 0 View adult BNF  View SPC online  View childrens BNF